Duncan John Higgons

Affiliations

  • Director at Jounce Therapeutics Inc. (JNCE), 2022-06-29
  • Chief Operating Officer at Agios Pharmaceuticals Inc (AGIO), 2016-01-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JNCE $16.00 6,700 $107,200.00 27,025 2017-02-01 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JNCE $10.00 200 $2,000.00 9,713 2021-04-15 Filing
JNCE $12.80 200 $2,560.00 9,913 2021-03-15 Filing
JNCE $11.78 200 $2,356.00 10,113 2021-02-16 Filing
JNCE $11.11 200 $2,222.00 10,313 2021-01-21 Filing
JNCE $12.00 1,500 $18,000.00 10,513 2021-01-20 Filing